Table 3.
miR | Leiomyomas | Endometrial sarcomas | Leiomyosarcomas | Mixed epithelial–mesenchymal tumors |
---|---|---|---|---|
miR-20a | ↑ [10] | ↑ | ↓ | ↑ |
miR-21 a | ↑ [10, 12] | ↓ | ↓ | ↓ |
miR-206 | ↑ [10] | ↑ | ↓ | ↑ |
miR-142-5p | ↓ [10] | ↑ | ↓ | ↑ |
let-7 familya | ↑ [12] | ↓ | ↓ | ↓ |
miR-23b a | ↑ [12] | ↓ | ↓ | ↓ |
miR-27a a | ↑ [12] | ↓ | ↓ | ↓ |
miR-29b | ↓ [12] | ↓ | ↓ | ↓ |
miR-32 a | ↓ [12] | ↑ | ↑ | ↑ |
miR-144 a | ↓ [12] | – | – | – |
miR-212 | ↓ [12] | ↓ | ↓ | ↓ |
“↑” – increased, “↓” – decreased, and “–” unchanged expression levels in tumors vs control samples
amiRs that are differentially expressed between malignant and benign lesions